Ligand Pharmaceuticals Incorporated (LGND) by event type
LGND moves most on coverage initiations — a median of -0.40% at 30 minutes across 19 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the LGND overview →
How LGND reacts across 3 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations 1,839 of 2,283 | 19 | -0.40% | 32% | +0.39% |
| Rating reiterations 463 of 3,522 | 67 | +0.20% | 66% | +0.32% |
| Price-target raises 876 of 1,790 | 35 | 0.00% | 49% | -0.05% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how LGND usually reacts — get an email when it moves on news →Every name measured for these event types: Coverage initiations → · Rating reiterations → · Price-target raises → · LGND overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | 368 | -0.13% | 49% |
| Arcus Biosciences, Inc. (RCUS) | 368 | -0.09% | 45% |
| Microbot Medical Inc. (MBOT) | 366 | -0.19% | 43% |
| SOPHIRIS BIO INC (SPHS) | 366 | -0.23% | 37% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.